Velo Freezing Peppermint 17mg
Velo Freezing Peppermint 17mg offers pouches with a peppermint flavour in a slim format. Each pouch has an extra strong strength, with 20 pouches per can.
In summer 2024, VELO introduces the Velo Freezing Peppermint 17mg. This product features a new design but keeps the same flavour of the existing VELO Freeze Max.
Read more about Velo Freezing Peppermint 17mg
More Information about Velo Freezing Peppermint 17mg
Read more about the product
Product Overview: Velo Freezing Peppermint 17mg
Velo Freezing Peppermint (Formerly VELO Freeze Max) is a nicotine pouch option under the VELO brand, manufactured by BAT. This Velo Nicotine Pouch product includes a peppermint flavour and is produced in a slim format. It contains nicotine and is categorised as extra strong, while it does not contain tobacco.
Flavour Profile
This Snus product product features a peppermint flavour.
Product Information:
- Category: Nicotine Pouches
- Flavour: Peppermint
- Strength Definition: Extra strong
- Manufacturer: BAT
- Nicotine mg/portion: 17
- Amount of bags/can: 20
About the VELO Brand
VELO is a tobacco-free nicotine pouch brand produced by British American Tobacco. Launched in 2022, VELO succeeded the LYFT series with a name change and new can design, maintaining the same standards of taste, nicotine content, and pouch shape. The brand offers a selection of flavours and nicotine strengths, made from plant-based materials.
Product Information
Read more about the product
| Brand | VELO |
| Format | Slim |
| Northerner's Strength | Extra Strong |
| Flavour | Mint |
| Flavour Notes | Peppermint, Menthol |
| Manufacturer's Strength | 6/6 |
| Product Type | Snus |
| Nicotine Content (mg/pouch) | 17 mg/portion |
| Nicotine Content (mg/g) | 31.8 mg/g |
| Pouches Per Can | 20 pcs |
| Product Series | VELO Nicotine Pouches |
| Manufacturer | BAT |
Reviews (0)
Read reviews about the product
Share your experience
If you’ve used this product, we’d love to hear what you think. Your feedback helps other customers make informed choices.